ELZITUDE
Live / Applied — Withdrawn from publication (as of 11 Jan 2022)
What this means for you
Not registered yet, but its 24 May 2021 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90729626
- Mark type
- Stylized text
- Filed
- 24 May 2021
- Attorney of record
- Marilyn F. Kelly
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; monoclonal antibodies
Owner
- Bristol-Myers Squibb Company, Princeton, NJ, US
Prosecution history
- 08 Dec 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 08 Dec 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 08 Dec 2024 — ASSIGNED TO LIE
- 02 Aug 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 02 Aug 2023 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 02 Aug 2023 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 23 Jun 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 11 Jan 2022 — WITHDRAWN FROM PUB - OG REVIEW QUERY
- 29 Dec 2021 — ASSIGNED TO LIE
- 28 Dec 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Dec 2021 — EXAMINER'S AMENDMENT ENTERED
- 27 Dec 2021 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 27 Dec 2021 — EXAMINERS AMENDMENT E-MAILED
- 27 Dec 2021 — EXAMINERS AMENDMENT -WRITTEN
- 27 Dec 2021 — ASSIGNED TO EXAMINER